Lucknow, India

Pallavi Hajela

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biocon Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pallavi Hajela. Retrieved from https://idiyas.com/inventor/pallavi-hajela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Pallavi Hajela

Introduction

Pallavi Hajela is an accomplished inventor based in Lucknow, India. She has made significant contributions to the field of biotechnology, particularly in the detection of antibodies related to insulin. Her work is vital for advancing diabetes management and treatment.

Latest Patents

Pallavi holds a patent for a method that detects neutralizing antibodies against recombinant human insulin in human serum. This invention provides an in vitro method for identifying the presence of these antibodies, which is crucial for ensuring the efficacy of insulin treatments. Additionally, her patent includes a kit designed for the detection of recombinant human insulin neutralizing antibodies.

Career Highlights

Pallavi is currently employed at Biocon Limited, a leading biopharmaceutical company in India. Her role at Biocon allows her to work on innovative solutions that address critical health challenges. Her expertise in biotechnology has positioned her as a key player in her field.

Collaborations

Pallavi collaborates with talented professionals, including Abhishek Kulshrestha and Ravi Shankar Maurya. These collaborations enhance her research and contribute to the development of groundbreaking technologies in the healthcare sector.

Conclusion

Pallavi Hajela's contributions to biotechnology, particularly through her patent on detecting insulin antibodies, highlight her innovative spirit and dedication to improving healthcare. Her work at Biocon Limited and collaborations with other professionals further emphasize her impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…